Evidence map›Paper›PMID 26923134›Full record

ArticleWorld journal of surgical oncology2016

Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.

Zhenzhong Su, Ke Wang, Ranwei Li, Jinzhi Yin, Yuqiu Hao, Xuejiao Lv, Junyao Li, Lijing Zhao, Yanwei Du, Ping Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Gene expression profiling after LINC00472 overexpression in an NSCLC cell line1.Cancer biomarkers : section A of Disease markers · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. [Expression and Clinical Significance of LC-3 and P62 
in Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhenzhong SuDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. su_zhenzhong@163.com.
Ke WangDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. kewangm1@hotmail.com.
Ranwei LiDepartment of Urinary Surgery, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. ranwei1968@yahoo.com.
Jinzhi YinDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. yjz6437@163.com.
Yuqiu HaoDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. hao.yu.qi.u@163.com.
Xuejiao LvDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. lvxuejiao0311@163.com.
Junyao LiDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. 13943175477@126.com.
Lijing ZhaoDepartment of Pathophysiology, Norman Bethune College of Medicine of Jilin University, Changchun, Jilin, 130021, People's Republic of China. zhao_lj@jlu.edu.cn.
Yanwei DuDepartment of Pathophysiology, Norman Bethune College of Medicine of Jilin University, Changchun, Jilin, 130021, People's Republic of China. 1079389886@qq.com.
Ping LiDepartment of Paediatrics, The Second Affiliated Hospital of Jilin University, Chuangchun, Jilin, 130041, People's Republic of China. lypinglp@163.com.
Jie ZhangDepartment of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. 18643111766@163.com.
Second Affiliated Hospital of Jilin University · CNFirst Bethune Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDysfunctions in autophagy and apoptosis are closely interacted and play an important role in cancer development. RNA binding motif 5 (RBM5) is a tumor suppressor gene, which inhibits tumor cells' growth and enhances chemosensitivity through inducing apoptosis in our previous studies. In this study, we investigated the relationship between RBM5 overexpression and autophagy in human lung adenocarcinoma cells.

methodsHuman lung adenocarcinoma cancer (A549) cells were cultured in vitro and were transiently transfected with a RBM5 expressing plasmid (GV287-RBM5) or plasmid with scrambled control sequence. RBM5 expression was determined by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blot. Intracellular LC-3 I/II, Beclin-1, lysosome associated membrane protein-1 (LAMP1), Bcl-2, and NF-κB/p65 protein levels were detected by Western blot. Chemical staining with monodansylcadaverine (MDC) and acridine orange (AO) was applied to detect acidic vesicular organelles (AVOs). The ultrastructure changes were observed under transmission electron microscope (TEM). Then, transplanted tumor models of A549 cells on BALB/c nude mice were established and treated with the recombinant plasmids carried by attenuated Salmonella to induce RBM5 overexpression in tumor tissues. RBM5, LC-3, LAMP1, and Beclin1 expression was determined by immunohistochemistry staining in plasmids-treated A549 xenografts.

resultsOur study demonstrated that overexpression of RBM5 caused an increase in the autophagy-related proteins including LC3-I, LC3-II, LC3-II/LC3-I ratio, Beclin1, and LAMP1 in A549 cells. A large number of autophagosomes with double-membrane structure and AVOs were detected in the cytoplasm of A549 cells transfected with GV287-RBM5 at 24 h. We observed that the protein level of NF-κB/P65 was increased and the protein level of Bcl-2 decreased by RBM5 overexpression. Furthermore, treatment with an autophagy inhibitor, 3-MA, enhanced RBM5-induced cell death and chemosensitivity in A549 cells. Furthermore, we successfully established the lung adenocarcinoma animal model using A549 cells. Overexpression of RBM5 enhanced the LC-3, LAMP1, and Beclin1 expression in the A549 xenografts.

conclusionsOur findings showed for the first time that RBM5 overexpression induced autophagy in human lung adenocarcinoma cells, which might be driven by upregulation of Beclin1, NF-κB/P65, and downregulation of Bcl-2. RBM5-enhanced autophagy acts in a cytoprotective way and inhibition of autophagy may improve the anti-tumor efficacy of RBM5 in lung cancer.

Indexed as

AdenocarcinomaAnimalsApoptosisAutophagyBlotting, WesternCell Cycle ProteinsDNA-Binding ProteinsFemaleHumansImmunoenzyme TechniquesLung NeoplasmsMiceMice, Inbred BALB CMice, NudeReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionCell Cycle ProteinsDNA-Binding ProteinsRBM5 protein, humanRNA-Binding ProteinsRNA, MessengerTumor Suppressor Proteins

Identifiers

PMID26923134
PMCPMC4770605
OpenAlexW2288882428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.